Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bioxcel Therapeutics Inc
(NQ:
BTAI
)
12.00
+0.26 (+2.21%)
Streaming Delayed Price
Updated: 3:59 PM EDT, May 16, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
308,629
Open
11.61
Bid (Size)
11.99 (2)
Ask (Size)
12.00 (4)
Prev. Close
11.74
Today's Range
11.33 - 12.45
52wk Range
9.080 - 39.00
Shares Outstanding
27,985,145
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
BioXcel Therapeutics: Q1 Earnings Insights
May 09, 2022
BioXcel Therapeutics (NASDAQ:BTAI) reported its Q1 earnings results on Monday, May 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Preview: BioXcel Therapeutics's Earnings
May 06, 2022
BioXcel Therapeutics (NASDAQ:BTAI) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that BioXcel...
Via
Benzinga
Performance
YTD
-47.44%
-47.44%
1 Month
-18.75%
-18.75%
3 Month
-31.78%
-31.78%
6 Month
-55.90%
-55.90%
1 Year
-61.35%
-61.35%
More News
Read More
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
May 01, 2022
Via
Benzinga
Oaktree, Qatar Investment Inject $260M In BioXcel To Fund Commercialization Of Schizophrenia Med
April 19, 2022
Via
Benzinga
Earnings Scheduled For March 10, 2022
March 10, 2022
Via
Benzinga
How To Attend BioXcel Therapeutics Q1 2022 Earnings Conference Call
April 27, 2022
Via
Benzinga
The Daily Biotech Pulse: Regeneron Acquires Checkmate Pharma, Moderna's Bivalent Booster COVID-19 Vaccine Update, Priority Review For AstraZeneca's Enhertu
April 19, 2022
Via
Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
April 10, 2022
Via
Benzinga
Looking Into Bioxcel Therapeutics Inc's Recent Short Interest
April 07, 2022
Via
Benzinga
Benzinga's Daily Brief On Trending Tickers For April 7, 2022: SDPR S&P 500, Houghton Mifflin, Sunshine Biopharma And More
April 07, 2022
Via
Benzinga
4 Top Stock Trades for Thursday: MSFT, TWTR, BTAI, PXD
April 06, 2022
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 06, 2022
Via
Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
April 06, 2022
Via
Benzinga
Why BioXcel Therapeutics Stock Is Surging Today
April 06, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 06, 2022
Via
Benzinga
FDA Approves BioXcel's Igalmi - First Orally Dissolving Sublingual Film For Schizophrenia-Associated Agitation
April 06, 2022
Via
Benzinga
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
April 06, 2022
Via
Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
April 05, 2022
Via
Benzinga
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
April 03, 2022
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
April 01, 2022
Via
Benzinga
Recap: BioXcel Therapeutics Q4 Earnings
March 10, 2022
Via
Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
March 06, 2022
Via
Benzinga
BioXcel BXCL701 Combo Therapy Shows Encouraging Response Rates In Prostate Cancer
February 15, 2022
Via
Benzinga
FDA Pushes Review Of BioXcel's Candidate For Agitation Associated With Neuropsychiatric Disorders
December 01, 2021
Via
Benzinga
Exposures
Product Safety
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.